Anzeige
Mehr »
Montag, 15.09.2025 - Börsentäglich über 12.000 News
Jetzt investieren - "Neubewertung Extrem" durch Übernahme?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JMW5 | ISIN: CA6823108759 | Ticker-Symbol:
NASDAQ
12.09.25 | 21:49
1,280 US-Dollar
-2,29 % -0,030
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ONCOLYTICS BIOTECH INC Chart 1 Jahr
5-Tage-Chart
ONCOLYTICS BIOTECH INC 5-Tage-Chart

Aktuelle News zur ONCOLYTICS BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ONCOLYTICS BIOTECH Aktie jetzt für 0€ handeln
08.09.Oncolytics Biotech Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions8
08.09.ONCOLYTICS BIOTECH INC - 6-K, Report of foreign issuer1
02.09.Stocks in Play: Oncolytics Biotech Inc-
02.09.Oncolytics Biotech Inc.: Oncolytics Biotech Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors90Data continue to demonstrate a favorable safety profile for pelareorep across multiple indications and in combination with multiple treatments Updated clinical data...
► Artikel lesen
28.08.Oncolytics Biotech Announces Upcoming Investor Conferences in September3
28.08.ONCOLYTICS BIOTECH INC - 6-K, Report of foreign issuer1
11.08.Oncolytics Biotech announces voting results from annual meeting1
11.08.Oncolytics Biotech Inc.: Oncolytics Biotech Announces Voting Results from the Annual General Meeting of Shareholders143SAN DIEGO, Aug. 11, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"), a clinical-stage...
► Artikel lesen
08.08.Oncolytics Biotech GAAP EPS of -$0.071
08.08.Stocks in Play: Oncolytics Biotech Inc1
08.08.Oncolytics Biotech to delist from Toronto Stock Exchange3
08.08.Oncolytics Biotech Inc.: Oncolytics Biotech Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep194Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members of...
► Artikel lesen
08.08.Oncolytics Biotech Inc.: Oncolytics Biotech Announces Voluntary Delisting from the Toronto Stock Exchange200SAN DIEGO, Aug. 8, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company...
► Artikel lesen
07.08.What to Expect from Oncolytics Biotech's Earnings1
05.08.ONCOLYTICS BIOTECH INC - 6-K, Report of foreign issuer1
05.08.Oncolytics Biotech Announces Upcoming Annual General Meeting and Second Quarter Financial Results1
29.07.Oncolytics Biotech to engage FDA on potential pancreatic cancer study1
29.07.Oncolytics Biotech im Dialog mit FDA über potenzielle Zulassungsstudie bei Bauchspeicheldrüsenkrebs4
29.07.Oncolytics Biotech sparks FDA discussions for potential pivotal pancreatic cancer trial2
29.07.Oncolytics Biotech Inc.: Oncolytics Biotech to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End171Clear regulatory path and strong survival data in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) support accelerated strategy to drive shareholder...
► Artikel lesen
Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1